Avatar for Neuroinitiative

Biotech to cure Neurodegenerative Disease

Biotech to cure Neurodegenerative Disease

First in class disease-modifying therapeutic molecules for Parkinson's disease. We aim to get these molecules to IND and out-license to pharma for human testing in 4 years. Average licensing options for similar compounds is $400mm (upfront and milestone based).

IP of company also includes patent-pending drug discovery simulation software, which we are not planning to out-license or sell at this point in time.
image

Andy D Lee

Avatar for Andy D Lee
Co-Founder and CTO of @Neuroinitiative and COO @Vincere Biosciences Previously VP Engineering at BKFS through Fort.500 acquisition and IPO.

Spring Behrouz

Avatar for Spring Behrouz
Co-founder and CEO @Vincere Biosciences and @Neuroinitiative • Previously did research at @Mayo Clinic • PhD in Neuroscience from @Michigan State University.

Neuroinitiative hasn't added any jobs yet

Get notified when Neuroinitiative posts new jobs.

See similar jobs